DadFinStart your free week
DadFin › Stocks › Healthcare › SOLV

Solventum Corporation (SOLV) stock score

Healthcare · Medical Instruments & Supplies · United States

$87.29 ▲ +1.02% today

71.9
Dad Score, out of 100
good

Solventum Corporation (SOLV) is a Medical Instruments & Supplies company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 71.9 out of 100 on the Dad Score, a good reading that places the business ahead of 72% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #245 of 974. Its strongest axes are valuation, quality and liquidity; its weakest are price action and risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Strong
Growth
Average
Price action
Below average
Risk
Below average
Conviction
Below average
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)10.7×
P/E (forward)12.2×
Dividend yield0.00%
Return on capital18.5%
Operating margin9.8%
Revenue growth (YoY)+0.9%
FCF yield-0.1%
Net debt / EBITDA4.29×
Piotroski F-Score6 / 9
52-week change+19.1%
Market cap$15.0B
Next earningsNov 5, 2026

What subscribers see on SOLV

Start your free weekSubscriber? Open the full research →

Medical Instruments & Supplies peers

StockCompanyDad ScoreBandMarket cap
ISRGIntuitive Surgical, Inc.87.0strong$140.4B
BDXBecton, Dickinson and Company69.8middling$48.2B
MDLNMedline Inc.98.2strong$47.9B
ALCAlcon Inc.64.6middling$30.8B
RMDResMed Inc.94.3strong$30.8B
WSTWest Pharmaceutical Services, Inc.90.1strong$25.7B
BAXBaxter International Inc.40.5middling$12.1B
COOThe Cooper Companies, Inc.99.6strong$10.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.